Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (71-80 of 246) with videos related to

Pageof 25
Sort By:
Haematologica|February 3, 2009
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stabilityGiovanna Meloni, Marco Mancini, Valentina Gianfelici, et al.
Haematologica|August 5, 2005
T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distributionKorinna Jöhrens, Yoshihiko Shimizu, Ioannis Anagnostopoulos, et al.
Journal of Theoretical Biology|July 26, 2005
Computational modeling of the immune response to tumor antigensFilippo Castiglione, Federico Toschi, Massimo Bernaschi, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci, et al.
Haematologica|October 9, 2002
Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemiaErica Finolezzi, Lilia Corral, Maria Paola Martelli, et al.
The Lancet. Oncology|January 1, 2004
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapyNiccolò Bolli, Mauro Di Ianni, Stefano Simonetti, et al.
Leukemia|March 24, 2018
IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategiesManja Meggendorfer, Luca Vincenzo Cappelli, Wencke Walter, et al.
Blood|October 30, 2010
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?Brunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
The Lancet. Oncology|February 6, 2004
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphomaArcangelo Liso, Enrico Tiacci, Roberto Binazzi, et al.
The Lancet. Oncology|March 8, 2019
Hairy cell leukaemia mimicking multiple myelomaLaura Notarfranchi, Filomena Russo, Francesca Re, et al.
Pageof 25

Showing results (71-80 of 246) with videos related to

Sort By:
Pageof 25
Haematologica|February 3, 2009
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stabilityGiovanna Meloni, Marco Mancini, Valentina Gianfelici, et al.
Haematologica|August 5, 2005
T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distributionKorinna Jöhrens, Yoshihiko Shimizu, Ioannis Anagnostopoulos, et al.
Journal of Theoretical Biology|July 26, 2005
Computational modeling of the immune response to tumor antigensFilippo Castiglione, Federico Toschi, Massimo Bernaschi, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci, et al.
Haematologica|October 9, 2002
Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemiaErica Finolezzi, Lilia Corral, Maria Paola Martelli, et al.
The Lancet. Oncology|January 1, 2004
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapyNiccolò Bolli, Mauro Di Ianni, Stefano Simonetti, et al.
Leukemia|March 24, 2018
IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategiesManja Meggendorfer, Luca Vincenzo Cappelli, Wencke Walter, et al.
Blood|October 30, 2010
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?Brunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
The Lancet. Oncology|February 6, 2004
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphomaArcangelo Liso, Enrico Tiacci, Roberto Binazzi, et al.
The Lancet. Oncology|March 8, 2019
Hairy cell leukaemia mimicking multiple myelomaLaura Notarfranchi, Filomena Russo, Francesca Re, et al.
Pageof 25